Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.

Liu Y, Chen Z, Liu C, Yu D, Lu Z, Zhang N.

Biomaterials. 2011 Aug;32(22):5167-76. doi: 10.1016/j.biomaterials.2011.03.077. Epub 2011 Apr 24.

PMID:
21521627
[PubMed - indexed for MEDLINE]
2.

Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.

Finn RS, Zhu AX.

Expert Rev Anticancer Ther. 2009 Apr;9(4):503-9. doi: 10.1586/era.09.6. Review.

PMID:
19374603
[PubMed - indexed for MEDLINE]
3.

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

Nagengast WB, de Vries EG, Hospers GA, Mulder NH, de Jong JR, Hollema H, Brouwers AH, van Dongen GA, Perk LR, Lub-de Hooge MN.

J Nucl Med. 2007 Aug;48(8):1313-9. Epub 2007 Jul 13.

PMID:
17631557
[PubMed - indexed for MEDLINE]
Free Article
4.

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

Hicklin DJ, Ellis LM.

J Clin Oncol. 2005 Feb 10;23(5):1011-27. Epub 2004 Dec 7. Review.

PMID:
15585754
[PubMed - indexed for MEDLINE]
5.

Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.

Li S, Peck-Radosavljevic M, Kienast O, Preitfellner J, Havlik E, Schima W, Traub-Weidinger T, Graf S, Beheshti M, Schmid M, Angelberger P, Dudczak R.

Q J Nucl Med Mol Imaging. 2004 Sep;48(3):198-206.

PMID:
15499293
[PubMed - indexed for MEDLINE]
Free Article
6.

Molecular targeting: targeting angiogenesis in solid tumors.

Soria JC, Fayette J, Armand JP.

Ann Oncol. 2004;15 Suppl 4:iv223-7. Review. No abstract available.

PMID:
15477311
[PubMed - indexed for MEDLINE]
Free Article
7.

Vascular endothelial growth factor: basic science and clinical progress.

Ferrara N.

Endocr Rev. 2004 Aug;25(4):581-611. Review.

PMID:
15294883
[PubMed - indexed for MEDLINE]
8.

Vascular endothelial growth factor as a target for anticancer therapy.

Ferrara N.

Oncologist. 2004;9 Suppl 1:2-10. Review.

PMID:
15178810
[PubMed - indexed for MEDLINE]
Free Article
9.

Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy.

Li S, Peck-Radosavljevic M, Kienast O, Preitfellner J, Hamilton G, Kurtaran A, Pirich C, Angelberger P, Dudczak R.

Ann Oncol. 2003 Aug;14(8):1274-7.

PMID:
12881392
[PubMed - indexed for MEDLINE]
Free Article
10.

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Wang YX, Hussain SM, Krestin GP.

Eur Radiol. 2001;11(11):2319-31. Review.

PMID:
11702180
[PubMed - indexed for MEDLINE]
11.

Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy.

Li S, Peck-Radosavljevic M, Koller E, Koller F, Kaserer K, Kreil A, Kapiotis S, Hamwi A, Weich HA, Valent P, Angelberger P, Dudczak R, Virgolini I.

Int J Cancer. 2001 Mar 15;91(6):789-96.

PMID:
11275981
[PubMed - indexed for MEDLINE]
12.

VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.

Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, Levi BZ, Neufeld G.

J Biol Chem. 1995 May 12;270(19):11322-6.

PMID:
7744769
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk